Completed
Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
NCT03959189
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disorders of Excessive Somnolence, Dyssomnias, +15 more
- Locations
-
- Stanford Neurosciences Health Center Palo Alto, California, United States
- Sleep Medicine Specialists of South Florida Miami, Florida, United States
- University of Iowa Iowa City, Iowa, United States
- The Center for Sleep & Wake Disorders Chevy Chase, Maryland, United States